Loading insider details...
Beta
Latest Form 4 (Sep 11, 2026): Grant/Award of 100,000 SCYX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | SCYNEXIS INC (SCYX) | Grant/Award | 100,000 | n/a |
| Mar 15, 2024 | Inozyme Pharma, Inc. (INZY) | Grant/Award | 165,000 | n/a |
| Jan 6, 2022 | Ocugen, Inc. (OCGN) | Grant/Award | 125,534 | n/a |
| Dec 18, 2021 | Ocugen, Inc. (OCGN) | Grant/Award | 35,560 | n/a |
| Nov 18, 2021 | Ocugen, Inc. (OCGN) | Grant/Award | 35,560 | n/a |
| Oct 27, 2021 | Ocugen, Inc. (OCGN) | Sale | 10,000 | $110.7K |
| Oct 15, 2021 | Ocugen, Inc. (OCGN) | Exercise/Conversion | 7,990 | $17.5K |
| Aug 18, 2021 | Ocugen, Inc. (OCGN) | Exercise/Conversion | 30,000 | $10.2K |
| Jul 16, 2021 | Ocugen, Inc. (OCGN) | Exercise/Conversion | 31,086 | $10.6K |
| Jun 17, 2021 | Ocugen, Inc. (OCGN) | Exercise/Conversion | 31,000 | $10.5K |